Literature DB >> 15677840

Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever.

Philippe Bossi1, Anders Tegnell, Agoritsa Baka, Frank Van Loock, Jan Hendriks, Albrecht Werner, Heinrich Maidhof, Georgios Gouvras.   

Abstract

Q fever is a zoonotic disease caused by Coxiella burnetii. Its interest as a potential biological weapon stems from the fact that an aerosol of very few organisms could infect humans. Another route of transmission of C. burnetii could be through adding it to the food supply. Nevertheless, C. burnetii is considered to be one of the less suitable candidate agents for use in a bioterrorist attack; the incubation is long, many infections are inapparent and the mortality is low. In the case of an intentional release of C. burnetii by a terrorist, clinical presentation would be similar to naturally occurring disease. It may be asymptomatic, acute, normally accompanied by pneumonia or hepatitis, or chronic, usually manifested as endocarditis. Most cases of acute Q fever are asymptomatic and resolve spontaneously without specific treatment. Nevertheless, treatment can shorten the duration of illness and decrease the risk of complications such as endocarditis. Post-exposure prophylaxis is recommended after the exposure in the case of a bioterrorist attack.

Entities:  

Mesh:

Year:  2004        PMID: 15677840

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

1.  65-year-old man with persistent fever.

Authors:  Zehra Haider; Constantine Tsigrelis; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

2.  Autoantibody profiles in the sera of patients with Q fever: characterization of antigens by immunofluorescence, immunoblot and sequence analysis.

Authors:  M T Camacho; I Outschoorn; A Tellez; J Sequí
Journal:  J Autoimmune Dis       Date:  2005-11-10

3.  Estimating the incubation period of acute Q fever, a systematic review.

Authors:  D Todkill; T Fowler; J I Hawker
Journal:  Epidemiol Infect       Date:  2018-03-21       Impact factor: 4.434

4.  Prophylaxis after exposure to Coxiella burnetii.

Authors:  Claire E Moodie; Herbert A Thompson; Martin I Meltzer; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.